Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.288.10.1252PMID 12215132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Applied Logistic Regression

  2002cited by this paper
• Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

  2002cited by this paper
• Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study.

  2002cited by this paper
• Heart Rate Recovery Immediately After Treadmill Exercise and Left Ventricular Systolic Dysfunction as Predictors of Mortality: The Case of Stress Echocardiography

  2001cited by this paper
• Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.

  2001cited by this paper
• Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels.

  2000cited by this paper
• Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study

  2000cited by this paper
• Clinical criteria and biochemical markers for the detection of systolic dysfunction.

  2000cited by this paper
• Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population

  2000cited by this paper
• Prevalence-value-accuracy plots: a new method for comparing diagnostic tests based on misclassification costs.

  1999cited by this paper
• Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population. The Tromsø Study.

  1999cited by this paper
• Biochemical detection of left-ventricular systolic dysfunction.

  1998influential reference
• Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?

  1998cited by this paper
• Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care

  1998cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Simplified echocardiography in the diagnosis of heart failure.

  1997cited by this paper
• Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

  1997cited by this paper
• Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

  1997cited by this paper
• Limited echocardiography for hypertensive left ventricular hypertrophy.

  1997cited by this paper
• Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

  1996cited by this paper
• Predictive properties of serum-prostate-specific antigen testing in a community-based setting.

  1996cited by this paper
• Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

  1996cited by this paper
• Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.

  1996cited by this paper
• Meta-analysis of Pap test accuracy.

  1995cited by this paper
• Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.

  1994cited by this paper
• Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients?

  1994cited by this paper
• Ruling Out or Ruling In Disease with the Most sensitiue or Specific Diagnostic Test

  1994cited by this paper
• Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.

  1993cited by this paper
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Enhancing and Evaluating Diagnostic Accuracy

  1991cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function.

  1984cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy.

  1982cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• An investigation of coronary heart disease in families. The Framingham offspring study.

  1979cited by this paper
• Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume.

  1978cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978influential reference
• Index for rating diagnostic tests

  1950cited by this paper

• Modulating CGRP Signaling: A Promising Therapeutic Avenue for Attenuating Cardiac Dysfunction in Heart Failure.

  2026cites this paper
• Use of NT‐proBNP for the screening, diagnosis and risk‐stratification of left ventricular dysfunction

  2025cites this paper
• Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024.

  2025cites this paper
• An Artificial Intelligence Algorithm for Early Detection of Left Ventricular Systolic Dysfunction in Patients with Normal Sinus Rhythm

  2025cites this paper
• Modern Understanding or Progress in the Causes and Prevention of Heart Failure

  2025cites this paper
• Artificial intelligence-enhanced six-lead portable electrocardiogram device for detecting left ventricular systolic dysfunction: a prospective single-centre cohort study

  2025cites this paper
• Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population.

  2025cites this paper
• Prognostic Value of B-Type Natriuretic Peptide Level in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction

  2025cites this paper
• Development and Validation of a Novel Machine Learning-Based Algorithm to Predict Incident Atrial Fibrillation - A Multicohort Analysis.

  2025cites this paper
• Association of obesity subphenotypes with indices of cardiac remodeling in the Framingham Heart Study.

  2025cites this paper
• AI-enabled cardiac chambers volumetry in coronary artery calcium scans (AI-CAC™) predicts heart failure and outperforms NT-proBNP: The multi-ethnic study of Atherosclerosis

  2024cites this paper
• AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CACTM) predicts atrial fibrillation as early as one year, improves CHARGE-AF, and outperforms NT-proBNP: The multi-ethnic study of atherosclerosis.

  2024cites this paper
• Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes

  2024cites this paper
• AI-powered Coronary Artery Calcium Scans (AI-CAC) Enables Prediction of Heart Failure and Outperforms NT-proBNP: The Multi-Ethnic Study of Atherosclerosis

  2024cites this paper
• Artificial intelligence-enhanced electrocardiography for accurate diagnosis and management of cardiovascular diseases.

  2024cites this paper
• AI-enabled Left Atrial Volumetry in Cardiac CT Scans Improves CHARGE-AF and Outperforms NT-ProBNP for Prediction of Atrial Fibrillation in Asymptomatic Individuals: Multi-Ethnic Study of Atherosclerosis

  2024cites this paper
• Cross-sectional Study of the Association between Plasma Brain Natriuretic Peptide Levels and Left Ventricular Shortening Fraction in Fukuyama Congenital Muscular Dystrophy.

  2024cites this paper
• AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI

  2024cites this paper
• Association of biomarkers of cardiac remodeling, myocardial fibrosis and inflammation with parameters of heart function and structure in patients with arterial hypertension.

  2024cites this paper
• Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk prediction

  2023cites this paper
• Study Protocol for the Pilot Evaluation for SMartphone-adaptable Artificial Intelligence for PRediction and DeTection of Left Ventricular Systolic Dysfunction (The SMART-LV Pilot Study Protocol)

  2023cites this paper
• Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease.

  2023cites this paper
• The Role of Serum NT-proBNP for Predicting Left Ventricular Systolic Dysfunction in Hospitalized Patients in Sri Lanka

  2023cites this paper
• Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction.

  2023cites this paper
• Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations

  2023cites this paper
• Biomarkers in heart failure: a focus on natriuretic peptides

  2023cites this paper
• Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices

  2023cites this paper
• The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients

  2023cites this paper
• Multimodal characterization of dilated cardiomyopathy: Geno‐ And Phenotyping of PrImary Cardiomyopathy (GrAPHIC)

  2023cites this paper
• Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta‐analysis

  2023influential citation
• Sensitive detection of heart-failure biomarkers natriuretic peptides using multi-photon laser wave-mixing spectroscopy.

  2022cites this paper
• Screening‐guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at‐risk patients

  2022cites this paper
• Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

  2022cites this paper
• Biomarkers in metabolic syndrome.

  2022cites this paper
• Physicians and Machine-Learning Algorithm Performance in Predicting Left-Ventricular Systolic Dysfunction from a Standard 12-Lead-Electrocardiogram

  2022cites this paper
• Artificial Intelligence-Augmented Electrocardiogram Detection of Left Ventricular Systolic Dysfunction in the General Population.

  2021cites this paper
• The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review

  2021cites this paper
• Differential impact of antihypertensive drugs on cardiovascular remodeling: a review of findings and perspectives for HFpEF prevention

  2021cites this paper
• Framingham Heart Study: JACC Focus Seminar, 1/8.

  2021cites this paper
• Heart failure risk estimation based on novel biomarkers

  2021cites this paper
• Cardiac troponin I measured with a very high sensitivity assay predicts subclinical carotid atherosclerosis: The Akershus Cardiac Examination 1950 Study.

  2021cites this paper
• Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study

  2021cites this paper
• Prevalence and Prognostic Value of Heart Failure Stages: An Elderly Inpatient Based Cohort Study

  2021cites this paper
• Lower B‐type natriuretic peptide levels predict left ventricular concentric remodelling and insulin resistance

  2021cites this paper
• Elevated BNP and High Brachial Pulse Pressure in Patients with Diabetes.

  2021cites this paper
• Artificial intelligence-enhanced electrocardiography in cardiovascular disease management

  2021cites this paper
• Combined Therapy with Rosiglitazone, Rofecoxib and Celecoxib Enhances Cardiovascular Side Effects through Cytochrome P450 Pathway of Arachidonic Acid Metabolism in Diabetic Arthritis Model Rats

  2020cites this paper
• Heart rate variability parameters among acute heart failure patients in a tertiary center in Nigeria

  2020cites this paper
• Diagnostic and Prognostic Value of N-Terminal Brain Natriuretic Peptide in Patients of Heart Failure

  2020cites this paper
• NT-proBNP and metabolic risk factors in a bi-ethnic cohort: the Ambulatory Blood Pressure in African prospective cohort study.

  2020cites this paper
• B-Type Natriuretic Peptide Is Associated with Indices of Left Ventricular Dysfunction in Healthy Subjects from the General Population: The Akershus Cardiac Examination 1950 Study.

  2020cites this paper
• Update: Therapie der chronischen Herzinsuffizienz

  2020cites this paper
• ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk

  2020cites this paper
• Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits

  2020cites this paper
• Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac Examination 1950 Study.

  2020cites this paper
• Update: Therapie der chronischen Herzinsuffizienz

  2020cites this paper
• Artificial Intelligence-Enabled ECG: a Modern Lens on an Old Technology

  2020cites this paper
• Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.

  2019cites this paper
• Evaluation of “point of care” brain natriuretic peptide level in differentiating between cardiogenic and noncardiogenic acute dyspnea (a hospital-based study)

  2019cites this paper
• Роль натрийуретических пептидов в определении тактики ведения недоношенных новорожденных с гемодинамически значимым функционирующим артериальным протоком

  2019cites this paper
• Update: Therapie der chronischen Herzinsuffizienz

  2019cites this paper
• Update: Therapie der chronischen Herzinsuffizienz

  2019cites this paper
• Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction.

  2019cites this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019cites this paper
• Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

  2019cites this paper
• 10-Year Risk Equations for Incident Heart Failure in the General Population.

  2019cites this paper
• Circulating microRNAs to predict heart failure after acute myocardial infarction in women.

  2019cites this paper
• 70-year legacy of the Framingham Heart Study

  2019cites this paper
• Asymptomatic Left Ventricle Systolic Dysfunction

  2019cites this paper
• Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study

  2019cites this paper
• Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors

  2019cites this paper
• Difference in the prevalence of subclinical left ventricular impairment among left ventricular geometric pattern in a community-based population.

  2019cites this paper
• Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies

  2018cites this paper
• Skin autofluorescence is associated with high-sensitive cardiac troponin T, a circulating cardiac biomarker, in Japanese patients with diabetes: A cross-sectional study

  2018cites this paper
• Association of N-Terminal Pro B-Type Natriuretic Peptide With Blood Pressure and Pulse Pressure in Elderly People　- A Cross-Sectional Population Study.

  2018cites this paper
• Update: Therapie der chronischen Herzinsuffizienz

  2018cites this paper
• The past, the present, and the future of natriuretic peptides in the diagnosis of heart failure

  2018cites this paper
• Sex Hormones and Change in N-Terminal Pro-B-Type Natriuretic Peptide Levels: The Multi-Ethnic Study of Atherosclerosis.

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• Exercise impedance cardiography reveals impaired hemodynamic responses to exercise in hypertensives with dyspnea

  2018cites this paper
• Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.

  2017influential citation
• Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress

  2017cites this paper
• Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects.

  2017cites this paper
• Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction

  2017cites this paper
• Ideal cardiovascular health and the subclinical impairments of cardiovascular diseases: a cross-sectional study in central south China

  2017cites this paper
• Pulmonary function and diffusion capacity are associated with pulmonary arterial systolic pressure in the general population: The Rotterdam Study.

  2017cites this paper
• Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost‐effectiveness Analysis

  2017cites this paper
• Community detection of non-ischemic stage B heart failure

  2017cites this paper
• B-type natriuretic peptide-guided treatment for heart failure: is the GUIDE-IT trail the end of the road?

  2017cites this paper
• Role of BNP as a Screening Tool to Identify Asymptomatic Cardiac Disease in Chronic Type 2 DM Patients

  2017cites this paper
• Korean Guidelines for Diagnosis and Management of Chronic Heart Failure

  2017cites this paper
• N-Terminal Pro-B-Type Natriuretic Peptide as a Diagnostic Test for Ventricular Dysfunction in Patients With Coronary Disease

  2016cites this paper
• Estimation Of Left Ventricular Ejection Fraction Using Mitral Annular Displacement Derived By Speckle Tracking Echocardiography In Patients With Different Heart Diseases

  2016cites this paper
• [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].

  2016cites this paper
• Novel insights into heart failure with preserved ejection fraction

  2016cites this paper
• Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromes.

  2016cites this paper
• The Association Between Alcohol Consumption and Left Ventricular Ejection Fraction

  2016cites this paper
• [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].

  2016cites this paper
• Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure

  2016cites this paper
• Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training.

  2016cites this paper